Which molecular biomarkers should be tested for non-small cell lung cancer

Biomarker Testing for Metastatic Non-Small Cell Lung Cancer

Great question! Biomarker testing is a crucial part of understanding your cancer and determining treatment options. Let me explain what doctors typically look for and why.

What Are Biomarkers?

Biomarkers are specific genetic mutations or proteins found in cancer cells. Think of them as "fingerprints" that help doctors understand how your cancer behaves and which treatments are most likely to work.

Standard Biomarkers Tested

According to the NCCN Guidelines for Patients: Metastatic Non-Small Cell Lung Cancer, doctors typically test for these driver mutations (genetic changes that help cancer cells grow):

For Adenocarcinoma, Large Cell Carcinoma, and Rare Cell Types:

• EGFR mutations (exon 19 deletion, L858R, S768I, L861Q, G719X, and exon 20 insertion)
• ALK rearrangement
• ROS1 rearrangement
• BRAF V600E mutation
• NTRK gene fusion
• MET exon 14 skipping
• RET rearrangement
• KRAS G12C mutation
• ERBB2 (HER2) mutation

For Squamous Cell Lung Cancer:

• Testing focuses on different biomarkers than adenocarcinoma

Additional Important Test:

• PD-L1 expression – This protein helps determine if immunotherapy (a type of treatment that boosts your immune system) might be effective

How Testing Works

The NCCN Guidelines note that biomarker testing can be done through:

• Tissue biopsy – A small sample of cancer cells examined in a lab
• Blood tests – Circulating tumor DNA (ctDNA) tests that detect cancer DNA fragments in your bloodstream

Why This Matters

Finding specific biomarkers is important because:

• Targeted therapy options – If you have certain mutations, doctors can prescribe medications specifically designed to block those mutations
• Treatment planning – Different biomarkers suggest different treatment approaches
• Predicting response – Some biomarkers help predict how well certain treatments will work

Questions to Ask Your Oncology Team

1. Which biomarkers have been tested in my cancer sample?
2. If some biomarkers weren't tested, why not, and should additional testing be done?
3. What do my specific biomarker results mean for my treatment options?
4. Are there any clinical trials available based on my biomarker profile?
5. How will my treatment plan change based on these results?

Important Reminder

Your oncologist will determine which specific biomarkers are most relevant for YOUR individual case and how to use these results to guide your treatment decisions. The complete picture—including your overall health, cancer stage, and other factors—all play a role in your personalized care plan.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.